ROCHE

Roche is a global pioneer in pharmaceuticals and diagnostics, dedicated to advancing science for the betterment of humanity. With a unique combination of strengths in pharmaceuticals and diagnostics under one roof, Roche leads the way in personalized healthcare, tailoring treatments to individual patients for optimal outcomes.

As the world's largest biotech company, Roche is at the forefront of innovation in oncology, immunology, infectious diseases, ophthalmology, and central nervous system disorders. Their commitment extends to in vitro diagnostics and tissue-based cancer diagnostics, along with a strong presence in diabetes management.

Founded in 1896, Roche continues to drive progress in disease prevention, diagnosis, and treatment while contributing sustainably to society. Roche collaborates with stakeholders to improve patient access to medical innovations. Notably, Roche's partnership with DeepReach enhances their capabilities in multi-location advertising campaigns, ensuring their mission reaches a broader audience.

Roche's impact on global health is exemplified by thirty of their medicines being included in the World Health Organization Model Lists of Essential Medicines. These life-saving antibiotics, antimalarials, and cancer treatments highlight Roche's commitment to healthcare worldwide. The company's dedication to sustainability has earned them recognition as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry for ten consecutive years, as acknowledged by the Dow Jones Sustainability Indices (DJSI).